Top 50 Cell Line Development in Africa

NewForm Foods utilizes cellular agriculture technology and proprietary bioprocessing to enable food producers and retailers to efficiently scale the production of cultivated meat and sustainable food products. By reducing capital and operational costs, the platform addresses the need for environmentally friendly food systems that do not compromise on taste or animal welfare.

Immobazyme produces recombinant growth factors for cellular agriculture using a modular protein expression system, enabling scalable and cost-effective solutions that eliminate the need for animal-derived products. The company also offers contract research services focused on waste valorization and downstream processing optimization, enhancing product efficiency and sustainability for various industries.

The startup develops a synthetic biology plant architecture that utilizes proprietary hyper-integration algorithms and precision fermentation to create customized modular plant systems at scale. This approach significantly reduces the time and costs associated with bringing synthetic biology products to market, addressing inefficiencies in traditional biomanufacturing processes.

This startup provides an AI-powered platform with advanced machine learning tools and algorithms to accelerate biomolecular design. It enables biotech companies to innovate faster and develop novel therapeutics by streamlining the design process.

GitLife Biotech provides a version control system for synthetic biology through its CellRepo™ platform, which organizes and secures data generated during strain engineering processes. This technology enhances traceability and ownership of biological assets by linking digital records to unique DNA Genosignatures®, ensuring precise documentation and compliance in genetic engineering.

MiGenTra develops biosimilars, cell and gene therapies, and vaccines to enhance access to high-quality medicines in Egypt, the Middle East, and Africa. By leveraging local manufacturing capabilities and expertise from ProBioGen and Minapharm Pharmaceuticals, the company addresses the need for affordable healthcare solutions in the region.

This company develops biological technology for efficient and scalable recombinant protein production. Their platform enables clients to produce high-quality, cost-effective recombinant proteins locally, streamlining the manufacturing process for various applications.

The startup operates a cell biobank that provides a diverse range of African species cell lines for the foodtech and biomedical sectors. This resource enables the development of sustainable biotechnological solutions that enhance biodiversity and improve global food security.

This company develops gene therapies for inherited retinal diseases, delivering normal gene copies to retinal cells to correct deficits caused by mutations. Their approach aims to either replace or silence disease-causing genes, potentially restoring vision for patients with genetic blindness.

Cellone develops modular and scalable smart solar power systems, known as PluGSpot, designed to provide reliable electricity for telecom infrastructure, homes, and enterprises in both off-grid and on-grid settings. These systems address the challenge of energy access by delivering cost-effective and efficient power solutions with a 99.9% uptime.

Hyperion FoodTech utilizes regenerative medicine and gene therapy technologies to develop sustainable food ingredients that enhance nutritional profiles and reduce reliance on traditional agriculture. This approach addresses food security challenges by providing alternative sources of essential nutrients while minimizing environmental impact.

Cape Bio Pharms produces recombinant proteins using Nicotiana benthamiana plants, which enhances yield and lowers production costs compared to conventional methods. This technology provides a scalable solution for efficient protein production in biopharmaceutical applications.